Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION (Tables)

v3.20.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Mar. 28, 2020
Share-based Payment Arrangement [Abstract]  
Total Stock-Based Compensation Cost and Associated Income Tax Benefits Related to Stock-Based Compensation Arrangements Recognized and Stock-Based Compensation Costs Included in Inventory
Total stock-based compensation cost and the associated income tax benefits recognized in the Consolidated Statements of Income, and stock-based compensation costs included in inventory in the Consolidated Balance Sheets, on a continuing operations basis, are as follows:
 
 
Year Ended March
 
Three Months
Ended March
(Transition Period)
 
Year Ended December
 
 
 
 
 
 
 
 
 
 
(In thousands)
 
2020
 
 
2019
 
2018
 
2017
Stock-based compensation cost
 
$
68,205

 
 
$
84,285

 
$
19,822

 
$
63,888

Income tax benefits
 
15,460

 
 
18,570

 
4,415

 
20,124

Stock-based compensation costs included in inventory at period end
 
1,903

 
 
2,555

 
1,861

 
1,347


Schedule of Assumption Used and Resulting Weighted Average Fair Value of Stock Option Granted
The grant date fair value of each option award is calculated using a lattice option-pricing valuation model, which incorporates a range of assumptions for inputs as follows:
 
 
Year Ended March
 
Three Months
Ended March
(Transition Period)
 
Year Ended December
 
 
 
 
 
 
 
 
 
 
 
 
2020
 
 
2019
 
2018
 
2017
Expected volatility
 
24% to 27%
 
 
22% to 29%
 
24% to 29%
 
23% to 30%
Weighted average expected volatility
 
25%
 
 
25%
 
25%
 
24%
Expected term (in years)
 
6.1 to 7.6
 
 
6.1 to 7.5
 
6.1 to 7.6
 
6.3 to 7.7
Weighted average dividend yield
 
2.5%
 
 
2.6%
 
2.9%
 
2.8%
Risk-free interest rate
 
1.4% to 2.4%
 
 
2.1% to 3.2%
 
1.9% to 2.9%
 
0.7% to 2.4%
Weighted average fair value at date of grant
 
$17.19
 
 
$16.82
 
$15.34
 
$9.90


Stock Option Activity
Stock option activity for the year ended March 2020 is summarized as follows:
 
Number of Shares
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term (Years)
 
Aggregate Intrinsic Value
(In thousands)
Outstanding, March 2019
9,910,210

 
$
60.11

 
 
 
 
Spin related adjustment
674,789

 

 
 
 
 
Transfer to Kontoor Brands
(756,709
)
 
62.51

 
 
 
 
Granted
1,512,955

 
84.27

 
 
 
 
Exercised
(3,290,971
)
 
53.53

 
 
 
 
Forfeited/cancelled
(129,272
)
 
70.78

 
 
 
 
Outstanding, March 2020
7,921,002

 
$
61.93

 
6.6
 
$
33,720

Exercisable, March 2020
5,897,457

 
$
55.66

 
5.9
 
$
33,681


RSU Activity
RSU activity for the year ended March 2020 is summarized as follows:
 
Performance-based
 
Nonperformance-based
 
Number Outstanding
 
Weighted Average
Grant Date
Fair Value
 
Number Outstanding
 
Weighted Average
Grant Date
Fair Value
Outstanding, March 2019
1,396,676

 
$
61.68

 
664,833

 
$
69.88

Spin related adjustment
63,336

 

 
44,933

 

Transfer to Kontoor Brands
(52,018
)
 
67.59

 
(79,187
)
 
71.19

Granted
275,092

 
84.28

 
196,621

 
84.22

Issued as Common Stock
(519,162
)
 
61.30

 
(235,604
)
 
66.44

Forfeited/cancelled
(23,673
)
 
66.26

 
(55,618
)
 
70.90

Outstanding, March 2020
1,140,251

 
$
63.51

 
535,978

 
$
70.50

Vested, March 2020
865,577

 
$
59.24

 
42,343

 
$
73.23



Restricted Stock Activity
Restricted stock activity for the year ended March 2020 is summarized below:
 
Nonvested Shares Outstanding
 
Weighted Average Grant Date Fair Value
Nonvested shares, March 2019
626,725

 
$
59.86

Spin related adjustment
39,434

 

Transfer to Kontoor Brands
(112,763
)
 
60.91

Granted
78,884

 
85.36

Dividend equivalents
13,580

 
78.24

Vested
(62,982
)
 
61.47

Forfeited
(40,046
)
 
59.47

Nonvested shares, March 2020
542,832

 
$
59.30